Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |